Mipomersen Approved (Bonus Antisense Roundup Included)

So Isis and their partner Sanofi have received FDA approval for mipomersen (branded as Kynamro). Late last year, the European Medicines Agency turned them down, which has people wondering about the drug's future, but here they are, albeit with a warning on the label about liver toxicity. Mipomersen is designed to lower the Apo-B lipoprotein in people with the most severe (homozygous) form of...